EUVIMEDEUVIMED entdecken
Crossref

Astaxanthin protects human astrocytes (HA) against 6-hydroxydopamine-induced oxidative toxicity

Sarah Hussein Ali Alallo, Zahraa A Althabet, Heba Akram Mohsin

Neurogenetics · 22.04.2026 · 27 (1)

DOI: 10.1007/s10048-026-00901-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogenetics, online erschienen am 22.04.2026. Verfasst von Sarah Hussein Ali Alallo und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Karbala, Karbala, Iraq. Hauptthemen laut MEDLINE: Oxidopamine, Astrocytes, Oxidative Stress, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: University of Warith Al-Anbiyaa (UOWA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

6-Hydroxydopamine (6-OHDA) induces dopaminergic degeneration via oxidative stress. Astaxanthin (AST), a potent antioxidant carotenoid, shows neuroprotective potential, but its effects on human astrocytes (HA) are not fully understood. This study investigated AST’s protective role against 6-OHDA-induced damage in HA cells. HA cells were pretreated with non-toxic AST concentrations (33, 66, 100 µM) before exposure to 6-OHDA (89 µM, IC₅₀). Viability (MTT assay), intracellular ROS, apoptosis, and cell cycle were analyzed by flow cytometry. Bax and Bcl-2 expression were assessed by real-time PCR and ELISA. 6-OHDA reduced viability by ~ 50%, increased ROS, induced G₀/G₁ arrest, and promoted apoptosis/necrosis. AST pretreatment dose-dependently improved viability, reduced ROS, alleviated cell cycle arrest, and decreased apoptotic/necrotic populations. AST also downregulated Bax and upregulated Bcl-2 at mRNA and protein levels, restoring apoptotic balance. AST protects HA cells from 6-OHDA-induced oxidative stress, apoptosis, and cell cycle disruption by modulating ROS and Bax/Bcl-2 pathways. These findings highlight AST’s potential as a neuroprotective agent in Parkinson’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidopamineAstrocytesOxidative StressNeuroprotective AgentsHumansXanthophyllsApoptosisReactive Oxygen SpeciesProto-Oncogene Proteins c-bcl-2Cell Survivalbcl-2-Associated X ProteinCells, CulturedCell CycleAntioxidants

Stichwörter der Autor:innen

6-hydroxydopamineApoptosisAstaxanthinCell cycle arrestHuman astrocytesOxidative stressROS

Substanzen

astaxanthineXanthophyllsOxidopamineReactive Oxygen SpeciesNeuroprotective AgentsProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinAntioxidants

Autor:innen und Institutionen

  • University of Karbala, Karbala, Iraq.
  • University of Warith Al-Anbiyaa, Karbala, Iraq. Zahraa.thabit11@gmail.com.
  • College of Pharmacy, University of Karbala, Karbala, Iraq.

Förderung

  • University of Warith Al-Anbiyaa (UOWA)

Zitieren

APA

Alallo, S. H. A., Althabet, Z. A., & Mohsin, H. A. (2026). Astaxanthin protects human astrocytes (HA) against 6-hydroxydopamine-induced oxidative toxicity. Neurogenetics, 27(1). https://doi.org/10.1007/s10048-026-00901-7

Vancouver

Alallo SHA, Althabet ZA, Mohsin HA. Astaxanthin protects human astrocytes (HA) against 6-hydroxydopamine-induced oxidative toxicity. Neurogenetics. 2026;27(1). doi:10.1007/s10048-026-00901-7

BibTeX
@article{Alallo2026,
  author = {Alallo, Sarah Hussein Ali and Althabet, Zahraa A and Mohsin, Heba Akram},
  title = {Astaxanthin protects human astrocytes (HA) against 6-hydroxydopamine-induced oxidative toxicity},
  journal = {Neurogenetics},
  year = {2026},
  volume = {27},
  number = {1},
  doi = {10.1007/s10048-026-00901-7}
}
Kostenlos starten →